heparosan conjugated doxorubicin (Caisson Biotech)

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug Nameheparosan conjugated doxorubicin (Caisson Biotech)
Drug Alias Namedoxorubicin
ClassificationSmall molecules > Carbohydrate > Oligosaccharide
Mechanisms of ActionTopoisomerase II inhibitorsVirus DNA polymerase inhibitorsDNA intercalators
TargetsVirus DNA polymeraseTopoisomerase IIDNA
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCaisson Biotech LLC
China Registration ClassN/A

Develop Information

Active CompaniesCaisson Biotech LLC
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A